Loading...
Header Logo
Keywords
Last Name
Institution

Professor Chandreshwar Prasad Thakur

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Sundar S, Pandey K, Thakur CP, Jha TK, Das VN, Verma N, Lal CS, Verma D, Alam S, Das P. Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study. PLoS Negl Trop Dis. 2014 Sep; 8(9):e3169. PMID: 25233346.
      View in: PubMed
    2. Rai AK, Thakur CP, Kumar P, Mitra DK. Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasis. Eur J Immunol. 2012 Oct; 42(10):2782-91. PMID: 22806538.
      View in: PubMed
    3. Rai AK, Thakur CP, Singh A, Seth T, Srivastava SK, Singh P, Mitra DK. Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis. PLoS One. 2012; 7(2):e31551. PMID: 22347492.
      View in: PubMed
    4. Rai AK, Thakur CP, Seth T, Mitra DK. Enrichment of invariant natural killer T cells in the bone marrow of visceral leishmaniasis patients. Parasite Immunol. 2011 Dec; 33(12):688-91. PMID: 21851364.
      View in: PubMed
    5. Sinha PK, Jha TK, Thakur CP, Nath D, Mukherjee S, Aditya AK, Sundar S. Phase 4 pharmacovigilance trial of paromomycin injection for the treatment of visceral leishmaniasis in India. J Trop Med. 2011; 2011:645203. PMID: 22174722.
      View in: PubMed
    6. Rai AK, Thakur CP, Velpandian T, Sharma SK, Ghosh B, Mitra DK. High concentration of adenosine in human visceral leishmaniasis despite increased ADA and decreased CD73. Parasite Immunol. 2011 Nov; 33(11):632-6. PMID: 21729107.
      View in: PubMed
    7. Rai AK, Thakur CP, Seth T, Mitra DK. Early activated Th-1 type and dominantly diverse natural killer T (CD3?CD161?Va24?) cells in bone marrow among visceral leishmaniasis patients. Int J Parasitol. 2011 Aug 15; 41(10):1069-77. PMID: 21787777.
      View in: PubMed
    8. Singh SP, Hirve S, Huda MM, Banjara MR, Kumar N, Mondal D, Sundar S, Das P, Gurung CK, Rijal S, Thakur CP, Varghese B, Kroeger A. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis. 2011 Feb 08; 5(2):e960. PMID: 21347452.
      View in: PubMed
    9. Thakur CP, Kumar A, Mitra DK, Roy A, Sinha AK, Ranjan A. Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride. Am J Trop Med Hyg. 2010 Nov; 83(5):1040-3. PMID: 21036834.
      View in: PubMed
    10. Hirve S, Singh SP, Kumar N, Banjara MR, Das P, Sundar S, Rijal S, Joshi A, Kroeger A, Varghese B, Thakur CP, Huda MM, Mondal D. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg. 2010 Sep; 83(3):507-11. PMID: 20810811.
      View in: PubMed
    11. Singh UK, Prasad R, Jaiswal BP, Singh PK, Thakur CP. Amphotericin B therapy in children with visceral leishmaniasis: daily vs. alternate day, a randomized trial. J Trop Pediatr. 2010 Oct; 56(5):321-4. PMID: 20065047.
      View in: PubMed
    12. Thakur CP, Meenakshi Thakur AK, Thakur S. Newer strategies for the kala-azar elimination programme in India. Indian J Med Res. 2009 Jan; 129(1):102-4. PMID: 19287067.
      View in: PubMed
    13. Narayan S, Gupta AK, Singh Subhankar K, Lal CS, Singh VP, Sinha PK, Das P, Thakur CP. Clinical and laboratory comparison of different brands of amphotericin B used for the treatment of Kala-azar: an observational study. J Commun Dis. 2008 Dec; 40(4):273-6. PMID: 19579720.
      View in: PubMed
    14. Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, Bhattacharya SK, Sinha A. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J Med Res. 2008 Jul; 128(1):38-44. PMID: 18820357.
      View in: PubMed
    15. Thakur CP, Thakur S, Narayan S, Sinha A. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate. Indian J Med Res. 2008 Jun; 127(6):582-8. PMID: 18765878.
      View in: PubMed
    16. Thakur CP. Tetany in kala azar patients treated with paromomycin. Indian J Med Res. 2008 May; 127(5):489-93. PMID: 18653914.
      View in: PubMed
    17. Thakur CP. A new strategy for elimination of kala-azar from rural Bihar. Indian J Med Res. 2007 Nov; 126(5):447-51. PMID: 18160749.
      View in: PubMed
    18. Thakur CP, Kumar A, Mitra G, Thakur S, Thakur M. Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine. Indian J Med Res. 2007 Jul; 126(1):73-5. PMID: 17890828.
      View in: PubMed
    19. Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H, Ganguly NK. Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis. 2007 Aug 15; 196(4):591-8. PMID: 17624846.
      View in: PubMed
    20. Sundar S, Jha TK, Thakur CP, Sinha PK, Bhattacharya SK. Injectable paromomycin for Visceral leishmaniasis in India. N Engl J Med. 2007 Jun 21; 356(25):2571-81. PMID: 17582067.
      View in: PubMed
    21. Sundar S, Jha TK, Thakur CP, Bhattacharya SK, Rai M. Oral miltefosine for the treatment of Indian visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2006 Dec; 100 Suppl 1:S26-33. PMID: 16730038.
      View in: PubMed
    22. Thakur CP. Leishmaniasis research - the challenges ahead. Indian J Med Res. 2006 Mar; 123(3):193-4. PMID: 16778302.
      View in: PubMed
    23. Jha TK, Sundar S, Thakur CP, Felton JM, Sabin AJ, Horton J. A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India. Am J Trop Med Hyg. 2005 Dec; 73(6):1005-11. PMID: 16354802.
      View in: PubMed
    24. Thakur CP, Narayan S, Ranjan A. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India. Indian J Med Res. 2004 Sep; 120(3):166-72. PMID: 15489554.
      View in: PubMed
    25. Thakur CP, Narayan S. A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis. Ann Trop Med Parasitol. 2004 Mar; 98(2):129-38. PMID: 15035723.
      View in: PubMed
    26. Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, Junge K, Karbwang J, Bryceson AD, Berman JD. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis. 2004 Jan 15; 38(2):217-21. PMID: 14699453.
      View in: PubMed
    27. Sundar S, Jha TK, Thakur CP, Mishra M, Singh VP, Buffels R. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study. Clin Infect Dis. 2003 Sep 15; 37(6):800-4. PMID: 12955641.
      View in: PubMed
    28. Thakur CP, Mitra DK, Narayan S. Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate. Trans R Soc Trop Med Hyg. 2003 Jul-Aug; 97(4):409-12. PMID: 15259468.
      View in: PubMed
    29. Thakur CP, Narayan S, Ranjan A. Kala-Azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: is this combination increasing? J Acquir Immune Defic Syndr. 2003 Apr 15; 32(5):572-3. PMID: 12679712.
      View in: PubMed
    30. Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med. 2002 Nov 28; 347(22):1739-46. PMID: 12456849.
      View in: PubMed
    31. Sundar S, Jha TK, Thakur CP, Mishra M, Singh VR, Buffels R. Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study. Am J Trop Med Hyg. 2002 Feb; 66(2):143-6. PMID: 12135284.
      View in: PubMed
    32. Thakur CP, Dedet JP, Narain S, Pratlong F. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India. Trans R Soc Trop Med Hyg. 2001 Mar-Apr; 95(2):187-9. PMID: 11355558.
      View in: PubMed
    33. Thakur CP. A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study. Int J Antimicrob Agents. 2001 Jan; 17(1):67-70. PMID: 11137652.
      View in: PubMed
    34. Thakur CP, Ahmed S. Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India. Indian J Med Res. 2001 Jan; 113:14-8. PMID: 11280166.
      View in: PubMed
    35. Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India. Trans R Soc Trop Med Hyg. 2000 Nov-Dec; 94(6):696-7. PMID: 11198660.
      View in: PubMed
    36. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Messick C, Olliaro P. Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans R Soc Trop Med Hyg. 2000 Jul-Aug; 94(4):432-3. PMID: 11127251.
      View in: PubMed
    37. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Zaniewski AE, Houlihan HH, Olliaro P. A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2000 Jul-Aug; 94(4):429-31. PMID: 11127250.
      View in: PubMed
    38. Thakur CP. Socio-economics of visceral leishmaniasis in Bihar (India). Trans R Soc Trop Med Hyg. 2000 Mar-Apr; 94(2):156-7. PMID: 10897353.
      View in: PubMed
    39. Jha TK, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, Voss A, Berman J. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med. 1999 Dec 09; 341(24):1795-800. PMID: 10588964.
      View in: PubMed
    40. Bodhe PV, Kotwani RN, Kirodian BG, Pathare AV, Pandey AK, Thakur CP, Kshirsagar NA. Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1999 May-Jun; 93(3):314-8. PMID: 10492769.
      View in: PubMed
    41. Thakur CP, Singh RK, Hassan SM, Kumar R, Narain S, Kumar A. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans R Soc Trop Med Hyg. 1999 May-Jun; 93(3):319-23. PMID: 10492770.
      View in: PubMed
    42. Thakur CP, Kumar P, Kumar N, Singh GN, Singh AK, Narain S. A randomized comparison of classical mode of administration of amphotericin B with its newer modes of administration in kala-azar. J Assoc Physicians India. 1998 Sep; 46(9):779-83. PMID: 11229246.
      View in: PubMed
    43. Thakur CP, Sinha GP, Pandey AK, Kumar N, Kumar P, Hassan SM, Narain S, Roy RK. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Ann Trop Med Parasitol. 1998 Jul; 92(5):561-9. PMID: 9797829.
      View in: PubMed
    44. Thakur CP. Sodium antimony gluconate, amphotericin, and myocardial damage. Lancet. 1998 Jun 27; 351(9120):1928-9. PMID: 9654264.
      View in: PubMed
    45. Jha TK, Olliaro P, Thakur CP, Kanyok TP, Singhania BL, Singh IJ, Singh NK, Akhoury S, Jha S. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ. 1998 Apr 18; 316(7139):1200-5. PMID: 9583927.
      View in: PubMed
    46. Berman JD, Badaro R, Thakur CP, Wasunna KM, Behbehani K, Davidson R, Kuzoe F, Pang L, Weerasuriya K, Bryceson AD. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ. 1998; 76(1):25-32. PMID: 9615494.
      View in: PubMed
    47. Thakur CP. A comparison of intercostal and abdominal routes of splenic aspiration and bone marrow aspiration in the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1997 Nov-Dec; 91(6):668-70. PMID: 9509175.
      View in: PubMed
    48. Thakur CP, Narain S, Kumar N, Hassan SM, Jha DK, Kumar A. Amphotericin B is superior to sodium antimony gluconate in the treatment of Indian post-kala-azar dermal leishmaniasis. Ann Trop Med Parasitol. 1997 Sep; 91(6):611-6. PMID: 9425363.
      View in: PubMed
    49. Jha TK, Thakur CP, Singh IJ, Singh TK, Jha S. Direct agglutination test for early diagnosis of Indian visceral leishmaniasis. J Assoc Physicians India. 1996 Sep; 44(9):606-8. PMID: 9251370.
      View in: PubMed
    50. Thakur CP, Pandey AK, Sinha GP, Roy S, Behbehani K, Olliaro P. Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Trans R Soc Trop Med Hyg. 1996 May-Jun; 90(3):319-22. PMID: 8758093.
      View in: PubMed
    51. Thakur CP, Sinha GP, Pandey AK. Comparison of regimens of amphotericin B deoxycholate in kala-azar. Indian J Med Res. 1996 May; 103:259-63. PMID: 8707361.
      View in: PubMed
    52. Thakur CP. Controversy in the regimens of treatment with amphotericin B in resistant cases of kala-azar. J Assoc Physicians India. 1995 Nov; 43(11):813-4. PMID: 8773056.
      View in: PubMed
    53. Thakur CP, Sinha GP, Barat D, Singh RK. Two-hour versus six-hour administration of amphotericin B in the treatment of kala-azar. Int J Antimicrob Agents. 1995 Apr; 5(2):115-7. PMID: 18611657.
      View in: PubMed
    54. Thakur CP, Bhowmick S, Dolfi L, Olliaro P. Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg. 1995 Mar-Apr; 89(2):219-23. PMID: 7778155.
      View in: PubMed
    55. Nuzum E, White F, Thakur C, Dietze R, Wages J, Grogl M, Berman J. Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood. J Infect Dis. 1995 Mar; 171(3):751-4. PMID: 7876635.
      View in: PubMed
    56. Thakur CP. Correction of serum electrolyte imbalance prevents cardiac arrhythmia during amphotericin B administration. Natl Med J India. 1995 Jan-Feb; 8(1):13-4. PMID: 7696938.
      View in: PubMed
    57. Thakur CP. Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar. Trans R Soc Trop Med Hyg. 1994 Nov-Dec; 88(6):698-9. PMID: 7886778.
      View in: PubMed
    58. Thakur CP, Sinha GP, Barat D, Singh RK. Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis? Ann Trop Med Parasitol. 1994 Aug; 88(4):365-70. PMID: 7979623.
      View in: PubMed
    59. Jha TK, Singh NK, Thakur CP, Singh TK. Incidence of HIV infection in resistant cases of Indian kala-azar. J Assoc Physicians India. 1994 Mar; 42(3):263. PMID: 7860533.
      View in: PubMed
    60. Gokhale PC, Kshirsagar NA, Khan MU, Pandya SK, Meisheri YV, Thakur CP, Choudhary CB. Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B. Trans R Soc Trop Med Hyg. 1994 Mar-Apr; 88(2):228. PMID: 8036684.
      View in: PubMed
    61. Thakur CP. A kala-azar control programme for remote tribal communities. World Health Forum. 1994; 15(3):245-7. PMID: 7945751.
      View in: PubMed
    62. Thakur CP, Sinha GP, Pandey AK, Barat D, Singh RK. Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison. Bull World Health Organ. 1994; 72(6):931-6. PMID: 7867139.
      View in: PubMed
    63. Thakur CP, Sinha GP, Sharma V, Barat D. The treatment of kala-azar during pregnancy. Natl Med J India. 1993 Nov-Dec; 6(6):263-5. PMID: 7950931.
      View in: PubMed
    64. Thakur CP, Sinha GP, Sharma V, Pandey AK, Kumar M, Verma BB. Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar. Indian J Med Res. 1993 Jul; 97:170-5. PMID: 8406644.
      View in: PubMed
    65. Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK. Amphotericin B in resistant kala-azar in Bihar. Natl Med J India. 1993 Mar-Apr; 6(2):57-60. PMID: 8477209.
      View in: PubMed
    66. Thakur CP, Sinha GP, Sharma V, Pandey AK, Sinha PK, Barat D. Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life. Indian J Pediatr. 1993 Jan-Feb; 60(1):29-36. PMID: 8244483.
      View in: PubMed
    67. Thakur CP, Olliaro P, Gothoskar S, Bhowmick S, Choudhury BK, Prasad S, Kumar M, Verma BB. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India. Trans R Soc Trop Med Hyg. 1992 Nov-Dec; 86(6):615-6. PMID: 1337634.
      View in: PubMed
    68. Thakur CP. Treatment of kala-azar in India. Natl Med J India. 1992 Sep-Oct; 5(5):203-5. PMID: 1338871.
      View in: PubMed
    69. Thakur CP, Kumar K. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol. 1992 Aug; 86(4):355-9. PMID: 1463355.
      View in: PubMed
    70. Thakur CP, Kumar M. Observations on the effect of verapamil with sodium stibogluconate in kala azar. Trop Geogr Med. 1992 Jan; 44(1-2):15-8. PMID: 1323160.
      View in: PubMed
    71. Thakur CP, Kumar M, Pandey AK. Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study. Am J Trop Med Hyg. 1991 Oct; 45(4):435-41. PMID: 1659239.
      View in: PubMed
    72. Thakur CP, Kumar M, Pandey AK. Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate. Indian J Med Res. 1991 Mar; 93:103-10. PMID: 1649790.
      View in: PubMed
    73. Thakur CP, Kumar K. Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis. Indian J Med Res. 1990 Mar; 91:144-8. PMID: 2160914.
      View in: PubMed
    74. Thakur CP, Sinha PK. Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar. J Trop Med Hyg. 1989 Dec; 92(6):383-5. PMID: 2607570.
      View in: PubMed
    75. Thakur CP, Thakur B, Singh S, Sinha PK, Sinha SK. The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits. Int J Cardiol. 1988 Nov; 21(2):167-75. PMID: 3225068.
      View in: PubMed
    76. Thakur CP, Kumar M, Kumar P, Mishra BN, Pandey AK. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study. Br Med J (Clin Res Ed). 1988 Jun 04; 296(6636):1557-61. PMID: 2840172.
      View in: PubMed
    77. Pandey AK, Kumar M, Thakur CP. ECG changes in prolonged treatment of kala-azar with antimony compounds. J Assoc Physicians India. 1988 Jun; 36(6):398-9. PMID: 2846508.
      View in: PubMed
    78. Thakur CP, Kumar K, Sinha PK, Mishra BN, Pandey AK. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate. Br Med J (Clin Res Ed). 1987 Oct 10; 295(6603):886-7. PMID: 2823955.
      View in: PubMed
    79. Thakur CP. Treatment for visceral leishmaniasis. J Assoc Physicians India. 1987 Sep; 35(9):641-3. PMID: 2830224.
      View in: PubMed
    80. Thakur CP, Thakur B, Singh S, Kumar B. Relation between full moon & medicolegal deaths. Indian J Med Res. 1987 Mar; 85:316-20. PMID: 3610276.
      View in: PubMed
    81. Thakur CP. Chemotherapy of leishmaniasis in India. Indian J Pediatr. 1987 Jan-Feb; 54(1):7-10. PMID: 3030933.
      View in: PubMed
    82. Thakur CP. Treatment of visceral leishmaniasis in Bihar. Trop Doct. 1986 Oct; 16(4):146-7. PMID: 3022433.
      View in: PubMed
    83. Thakur CP. Harmful effect of high stibogluconate treatment of kala-azar in India. Trans R Soc Trop Med Hyg. 1986; 80(4):672-3. PMID: 3027929.
      View in: PubMed
    84. Thakur CP. Treatment of visceral leishmaniasis. J Assoc Physicians India. 1985 May; 33(5):379-80. PMID: 2995305.
      View in: PubMed
    85. Thakur CP, Kumar M, Singh SK, Sharma D, Prasad US, Singh RS, Dhawan PS, Achari V. Comparison of regimens of treatment with sodium stibogluconate in kala-azar. Br Med J (Clin Res Ed). 1984 Mar 24; 288(6421):895-7. PMID: 6322906.
      View in: PubMed
    86. Thakur CP, Mandal K. Effect of Emblica officinalis on cholesterol-induced atherosclerosis in rabbits. Indian J Med Res. 1984 Jan; 79:142-6. PMID: 6724650.
      View in: PubMed
    87. Thakur CP. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis). Trans R Soc Trop Med Hyg. 1984; 78(3):391-8. PMID: 6087515.
      View in: PubMed
    88. Thakur CP, Kumar A. Electrolyte excretion pattern of normal and hypertensive. Indian Heart J. 1983 Nov-Dec; 35(6):329-32. PMID: 6667949.
      View in: PubMed
    89. Thakur CP. Leishman-Donovan bodies in the duodenal mucosa of a child with kala-azar. Br Med J (Clin Res Ed). 1983 Oct 22; 287(6400):1221. PMID: 6414637.
      View in: PubMed
    90. Thakur CP, Sharma RN. Epidemic dropsy with unusual features. Trop Doct. 1983 Apr; 13(2):55-6. PMID: 6679396.
      View in: PubMed
    91. Thakur CP, Ali M. Egg protein and defatted soya protein on cholesterol induced hypercholesterolaemia and atherosclerosis in rabbits. Indian J Med Res. 1982 Jun; 75:862-7. PMID: 6890043.
      View in: PubMed
    92. Thakur CP, Kumar M, Pathak PK. Kala-azar hits again. J Trop Med Hyg. 1981 Dec; 84(6):271-6. PMID: 7321074.
      View in: PubMed
    93. Thakur CP, Sinha KP, Gupta AK, Kumar SC. Study of the outbreak of kala-azar epidemic in Bihar. J Assoc Physicians India. 1978 Jun; 26(6):511-8. PMID: 721754.
      View in: PubMed
    94. Thakur CP. Study of 250 cases of tropical eosinophilia. Indian J Chest Dis. 1971 Oct; 13(4):140-7. PMID: 5148085.
      View in: PubMed
    95. Thakur CP. Studies of mortality from rheumatic heart disease. Indian Heart J. 1969 Jan; 21(1):61-8. PMID: 5783201.
      View in: PubMed
    Thakur's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description